Please login to the form below
About us
The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly print title Communiqué are published by PMGroup. They offer the latest pharma news, analysis, jobs and events, including the annual Pharmaceutical Market Excellence Awards (PMEAs) and Communiqué Awards.
General enquiries
Email: info@pmlive.com
The team
EDITORIAL
Email: editor@pmlive.com
Iona Everson - Group Managing Editor, PMGroup
Email: ieverson@pmlive.com
Tel: +44 (0)1372 414 281
Lucy Parsons - Reporter, PMGroup
Email: lparsons@pmlive.com
Tel: +44 (0)1372 414 285
Twitter: @pme_pharma
AWARDS
Debbie Tuesley
Email: dtuesley@pmlive.com
Tel: +44 (0)1372 414 243
DESIGN AND PRODUCTION
Helen Penfold - Middleweight Graphic Designer
Email: hpenfold@pmlive.com
Tel: +44 (0)1372 414 272
Anamaria Popescu - Front-End Developer
Email: apopescu@pmlive.com
Tel: +44 (0)1372 414 262
SUBSCRIPTIONS
Email: subscriptions@pmlive.com
Tel: +44 (0)1372 414 200
BUSINESS DIRECTOR
Tara Lovegrove
Email: tlovegrove@pmlive.com
Tel: +44 (0)1372 414 242
BUSINESS DEVELOPMENT
Eliot Haynes - Key Account Manager
Email: ehaynes@pmlive.com
Tel: +44 (0)1372 414 220
EXECUTIVE DIRECTOR
Karl Equi
Email: kequi@pmlive.com
Tel: +44 (0)1372 414 270
ADDRESS
PMGroup Worldwide Ltd
Mansard House
Church Road
Little Bookham
Surrey
KT23 3JG
Telephone: +44 (0)1372 414200
SOCIAL MEDIA
Twitter: @pmlivecom
LinkedIn Group: PME (PMLiVE.com) Network
LinkedIN Company Page: PMGroup Worldwide Ltd
Facebook: PMLiVE
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
nzyme
The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
